Can Fite Biopharma Ltd (CANF) — Net Asset Momentum
Can Fite Biopharma Ltd (CANF) recorded a net asset momentum of 2.9% as of December 2025, with net assets of ILA5.59 Million ILA. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See CANF days of operational coverage to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Can Fite Biopharma Ltd Net Asset Momentum (2003–2025)
This chart tracks Can Fite Biopharma Ltd's year-over-year net asset growth across 23 annual reporting periods from 2003 to 2025. The most recent momentum reading is +2.9%, with net assets of ILA5.59 Million ILA as of December 2025. Read how much debt does Can Fite Biopharma Ltd carry for a breakdown of total debt and financial obligations.
Annual Net Asset History for Can Fite Biopharma Ltd (2003–2025)
The table below shows the complete annual net asset history for Can Fite Biopharma Ltd from 2003 to 2025, covering 23 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see market value of Can Fite Biopharma Ltd.
| Year | Net Assets (ILA) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | ILA5.59 Million | ILA9.52 Million | ILA3.92 Million | ▲ +2.9% |
| 2024 | ILA5.44 Million | ILA9.12 Million | ILA3.68 Million | ▼ -12.9% |
| 2023 | ILA6.24 Million | ILA9.99 Million | ILA3.75 Million | ▲ +39.6% |
| 2022 | ILA4.47 Million | ILA9.28 Million | ILA4.81 Million | ▼ -68.9% |
| 2021 | ILA14.38 Million | ILA20.25 Million | ILA5.87 Million | ▲ +136.8% |
| 2020 | ILA6.07 Million | ILA9.52 Million | ILA3.45 Million | ▲ +148.7% |
| 2019 | ILA2.44 Million | ILA8.17 Million | ILA5.73 Million | ▼ -19.0% |
| 2018 | ILA3.02 Million | ILA7.95 Million | ILA4.94 Million | ▼ -1.3% |
| 2017 | ILA3.05 Million | ILA7.83 Million | ILA4.78 Million | ▼ -21.2% |
| 2016 | ILA3.87 Million | ILA10.17 Million | ILA6.29 Million | ▼ -62.9% |
| 2015 | ILA10.44 Million | ILA17.60 Million | ILA7.16 Million | ▲ +52.3% |
| 2014 | ILA6.86 Million | ILA10.19 Million | ILA3.33 Million | ▲ +53.8% |
| 2013 | ILA4.46 Million | ILA6.63 Million | ILA2.18 Million | ▲ +729.7% |
| 2012 | ILA-707.99K | ILA1.64 Million | ILA2.34 Million | ▼ -121.5% |
| 2011 | ILA3.29 Million | ILA4.90 Million | ILA1.61 Million | ▼ -74.8% |
| 2010 | ILA13.07 Million | ILA18.55 Million | ILA5.47 Million | ▼ -3.1% |
| 2009 | ILA13.49 Million | ILA20.10 Million | ILA6.62 Million | ▼ -8.8% |
| 2008 | ILA14.79 Million | ILA21.86 Million | ILA7.07 Million | ▼ -61.8% |
| 2007 | ILA38.70 Million | ILA48.94 Million | ILA10.23 Million | ▲ +0.9% |
| 2006 | ILA38.34 Million | ILA41.76 Million | ILA3.42 Million | ▲ +7.0% |
| 2005 | ILA35.83 Million | ILA37.09 Million | ILA1.26 Million | ▲ +2082.8% |
| 2004 | ILA-1.81 Million | ILA1.28 Million | ILA3.09 Million | ▼ -187.3% |
| 2003 | ILA2.07 Million | ILA2.71 Million | ILA642.00K | — |